Terms: = Kidney tumors AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
101 results:
1. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract] [Full Text] [Related]
2. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
3. SLFN11 promotes clear cell renal cell carcinoma progression via the pi3k/AKT signaling pathway.
Wang HX; Zhao ZP; Du XY; Peng SL; Xu HY; Tang W; Yang L
Med Oncol; 2024 Jan; 41(2):54. PubMed ID: 38206539
[TBL] [Abstract] [Full Text] [Related]
4. ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating pi3k/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma.
Wang X; Yao L; Li Z; Zhang J; Ruan M; Mulati Y; Gan Y; Zhang Q
Int J Biol Sci; 2024; 20(2):643-663. PubMed ID: 38169650
[No Abstract] [Full Text] [Related]
5. Doxycycline hydrochloride inhibits the progress of malignant rhabdoid tumor of kidney by targeting MMP17 and MMP1 through pi3k-Akt signaling pathway.
Mi T; Zhang Z; Zhanghuang C; Jin L; Tan X; Liu J; Wu X; Li M; Wang J; Wang Z; Guo P; He D
Eur J Pharmacol; 2024 Feb; 964():176291. PubMed ID: 38158115
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Expression and Prognostic Implications of Krüppel-Like Factor 3 (KLF3) in Clear Cell Renal Cell Carcinoma.
Wan B; Zhang W; Deng X; Lu Y; Zhang Z; Yang Y
Crit Rev Eukaryot Gene Expr; 2024; 34(2):45-59. PubMed ID: 38073441
[TBL] [Abstract] [Full Text] [Related]
7. SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification.
Wang H; Ma X; Li S; Ni X
Aging (Albany NY); 2023 Nov; 15(22):13150-13162. PubMed ID: 37993256
[TBL] [Abstract] [Full Text] [Related]
8. High PAQR4 mRNA Expression May Play a Key Role in prognosis of kidney Renal Papillary Cell Carcinoma.
Liu C; Cai W; Tang P; Li C
Ann Clin Lab Sci; 2023 Sep; 53(5):701-711. PubMed ID: 37945022
[TBL] [Abstract] [Full Text] [Related]
9. The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma.
Yang Y; Liang J; Zhao J; Wang X; Feng D; Xu H; Shen Y; Zhang Y; Dai J; Wang Z; Wei Q; Liu Z
Diagn Pathol; 2023 Aug; 18(1):96. PubMed ID: 37608295
[TBL] [Abstract] [Full Text] [Related]
10. pi3k/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation.
Rezaei S; Nikpanjeh N; Rezaee A; Gholami S; Hashemipour R; Biavarz N; Yousefi F; Tashakori A; Salmani F; Rajabi R; Khorrami R; Nabavi N; Ren J; Salimimoghadam S; Rashidi M; Zandieh MA; Hushmandi K; Wang Y
Eur J Pharmacol; 2023 Sep; 955():175909. PubMed ID: 37490949
[TBL] [Abstract] [Full Text] [Related]
11. The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma.
Nunes-Xavier CE; Emaldi M; Mingo J; Øyjord T; Mælandsmo GM; Fodstad Ø; Errarte P; Larrinaga G; Llarena R; López JI; Pulido R
Sci Rep; 2023 May; 13(1):7339. PubMed ID: 37147361
[TBL] [Abstract] [Full Text] [Related]
12. BKM120 inhibits malignant rhabdoid tumor of the kidney through induction of apoptosis and G0/G1 phase arrest.
Liu J; Mi T; Zhang Z; Jin L; Li M; Zhanghuang C; Li M; Wang J; Wu X; Wang Z; Tan X; Wang Z; He D
Eur J Pharmacol; 2023 Jul; 951():175747. PubMed ID: 37142086
[TBL] [Abstract] [Full Text] [Related]
13. Risk signature identification and NPRL2 affects sunitinib sensitivity in clear cell renal cell carcinoma.
Du X; Zhao Z; Zhao X; Wang H; Jiang L; Tang W
Biochem Biophys Res Commun; 2023 Jun; 663():122-131. PubMed ID: 37121122
[TBL] [Abstract] [Full Text] [Related]
14.
Qiao L; Zhang L; Wang H
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107702
[TBL] [Abstract] [Full Text] [Related]
15. Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort study.
Myint KZY; Shimabuku M; Horio R; Kaneda M; Shimizu Y; Taguchi J
Cancer Treat Res Commun; 2023; 35():100701. PubMed ID: 37094468
[TBL] [Abstract] [Full Text] [Related]
16. PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.
Qin C; Liu S; Zhou S; Wang Q; Xia X; Hu J; Yuan X; Wang Z; Yu Y; Ma D
Front Immunol; 2023; 14():1114572. PubMed ID: 37063922
[TBL] [Abstract] [Full Text] [Related]
17. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract] [Full Text] [Related]
18. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
Zhou S; Lu Y; Chen Y; Gan W
Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
[TBL] [Abstract] [Full Text] [Related]
19. A rare case of Klippel-Trenaunay syndrome presenting with chronic myeloid leukemia.
Coşkun Ç; Aksu T; Gümrük F; Ünal Ş
Turk J Pediatr; 2023; 65(1):124-128. PubMed ID: 36866992
[TBL] [Abstract] [Full Text] [Related]
20. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
[TBL] [Abstract] [Full Text] [Related]
[Next]
